Table 4 The number of patients whose ammonia level increased to greater than 80 µmol/L in patients with or without portosystemic collaterals.

From: Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy

 

NH3 < 80 µmol

NH3 ≥ 80 µmol

Portosystemic collaterals (−)

13

0

Portosystemic collaterals (+)

7

3

  1. Fisher exact test: P = 0.068.